FDA approves first drug to delay onset of Type 1 diabetes

Published



The Food and Drug Administration approved a new drug on Thursday that may postpone the onset of Type 1 diabetes, becoming the first of its kind to delay the chronic condition.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.